Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genetic Signatures Ltd. ( (AU:GSS) ) has issued an announcement.
Genetic Signatures Limited has notified the market of the cessation of certain securities following the lapse of conditional rights attached to two option classes. A total of 247,500 options under the GSSAB code and 40,000 options under the GSSAC code have expired as the conditions for their exercise were not satisfied, resulting in a reduction of potential future dilution for existing shareholders and a modest simplification of the company’s capital structure.
The most recent analyst rating on (AU:GSS) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Genetic Signatures Ltd. stock, see the AU:GSS Stock Forecast page.
More about Genetic Signatures Ltd.
Genetic Signatures Ltd. is an Australian-listed biotechnology company trading under the ASX code GSS. The company operates in the life sciences sector, focusing on the development and commercialisation of molecular diagnostic technologies and related products for medical and research markets.
Average Trading Volume: 223,216
Technical Sentiment Signal: Sell
Current Market Cap: A$32.94M
Find detailed analytics on GSS stock on TipRanks’ Stock Analysis page.